Sycamore

Sycamore is a pharmacist based in Christchurch, New Zealand, who has been a strong advocate for pharmacogenomic testing after her own experiences with pain management revealed a genetic issue affecting her response to painkillers. After discovering she has reduced activity in the enzyme CYP2D6, which is crucial for metabolizing certain medications, she launched PGx Health to provide genetic testing services aimed at improving medication efficacy for patients, particularly those with mental health issues.